Risk factor control in the hypertensive patients with chronic ischemic heart disease attended in cardiologic outpatient clinics. The CINHTIA study;Control de los factores de riesgo en los pacientes hipertensos con cardiopatía isquémica crónica atendidos en las consultas de cardiología. Estudio CINHTIA

Revista Clinica Espanola

Volumn 208, Issue 8, 2008, Pages 400-404

  Barrios Alonso, V ^a,d   Escobar, C ^a   Bertomeu, V ^b   Murga, N ^a   De Pablo, C ^c   Calderon A ^a  

^a Sección de Cardiología Clínica Y Extrahospitalaria   (Spain)

^b Grupo de Trabajo de Diabetes Y Corazón   (Spain)

^c Sección de Cardiología Preventiva Y Rehabilitación   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Cardiologist setting; Chronic ischemic heart disease; Hypertension

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOLOGIST; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL FEATURE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HEART MUSCLE ISCHEMIA; HIGH RISK POPULATION; HUMAN; HYPERTENSION; HYPOLIPEMIA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; AGED; CHRONIC DISEASE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; MULTICENTER STUDY;

AGED; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MYOCARDIAL ISCHEMIA; RISK FACTORS;

EID: 59449092411     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1157/13126342     Document Type: Article

References (15)

1. Baena JM, del Val JL, Tomás J, Martínez JL, Martín R, González I, et al. Epidemiología de las enfermedades cardiovasculares y factores de riesgo en atención primaria. Rev Esp Cardiol. 2005;58:367-73.
2. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-13.
3. Anguita M, Rodríguez M, Ojeda S, Ruiz M, Romo E, Mesa D, et al. Evolución clínica y reversibilidad de la disfunción sistólica en pacientes con miocardiopatía dilatada hipertensiva e insuficiencia cardiaca crónica. Rev Esp Cardiol. 2004;57:834-41.
4. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease. Hypertension. 2001;37:1053-9.
5. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-53.
6. Clark A, Hartling L, Vandermeer B, McAlister FA. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med. 2005;143:659-72.
7. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
8. American Diabetes Association. Clinical Practice Recommendations 2005. Diabetes Care. 2005;28 Suppl 1:S1-79.
9. Barrios V, Escobar C, Llisterri JL, Calderón A, Alegría E, Muñiz J, et al. Control de presión arterial y de lípidos y su relación con el riesgo coronario en una población hipertensa atendida en Atención Primaria en España. Estudio PRESCOT. Rev Clin Esp. 2007;207:172-8.
10. Tranche S, López I, Mostaza JM, Soler B, Mantilla MT, Taboada M, et al. Control de factores de riesgo coronario en prevención secundaria: estudio PRESENAP. Med Clin. 2006;127:765-9.
11. Bhatt DL, Steg PG, Ohman EM, Hirsh AT, Ikeda Y, Mas JL, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295:180-9.
12. Barrios V, Banegas JR, Ruilope LM, Rodicio JL. Evolution of blood pressure control in Spain. J Hypertens. 2007;25:1975-7.
13. González JR, Alegría E, Lozano JV, Llisterri JL, García JM, González I. Impacto de la hipertensión en las cardiopatías en España. Estudio CARDIOTENS 1999. Rev Esp Cardiol. 2001;54:1398-149.
14. Grupo Barbanza para el estudio de las enfermedades cardiovasculares. Características de los pacientes con cardiopatías en un área sanitaria de la provincia de A Coruña. Estudio Barbanza 2000. Rev Clin Esp. 2003;203:570-6.
15. Morise A, Evans M, Jalisi F, Shetty R, Stauffer M. A pretest prognostic score to assess patients undergoing exercise or pharmacological stress testing. Heart. 2007;93:200-4.